VCANBIO CELL & GENE ENGINEERING CORP., LTD Quotes Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.97 CNY | +3.16% |
|
+10.05% | -16.28% |
Quotes 5-day view
End-of-day quote Shanghai S.E.| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | Today | 2024-04-28 | |
|---|---|---|---|---|---|---|
| Last | 15.91 ¥ | 16.13 ¥ | 16.33 ¥ | 16.45 ¥ | 16.97 ¥ | 16.97 ¥ |
| Volume | 3 544 628 | 3 420 213 | 4 311 099 | 4 613 369 | 6 362 100 | 6 362 100 |
| Change | +1.73% | +1.38% | +1.24% | +0.73% | +3.16% | +3.16% |
| Opening | 15.60 | 15.71 | 16.18 | 16.29 | 16.46 | 16.46 |
| High | 16.02 | 16.15 | 16.50 | 16.47 | 17.06 | 17.06 |
| Low | 15.50 | 15.71 | 16.04 | 16.10 | 16.45 | 16.45 |
Performance
| 1 day | +3.16% | ||
| 1 week | +10.05% | ||
| Current month | +3.48% | ||
| 1 month | +4.37% | ||
| 3 months | -2.25% | ||
| 6 months | -9.69% | ||
| Current year | -16.28% | ||
| 1 year | -6.19% | ||
| 3 years | -16.32% | ||
| 5 years | -17.26% | ||
| 10 years | -26.09% |
Volumes
marketsDaily volume
6 362 100
Avg. Volume 20 sessions
4 441 718
Avg. Volume 20 sessions CNY
75 375 954.46
Avg. Volume 20 sessions USD
10 423 589.99
Record volume 1
95 313 300
Record volume 2
58 206 380
Record volume 3
48 009 940
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (CNY)
7 681 703 228
Capitalization (USD)
1 062 287 376
Net sales (CNY)
1 589 723 333
Net sales (USD)
219 839 660
Number of employees
2 332
Sales / Employee (CNY)
681 700
Sales / Employee (USD)
94 271
Free-Float
71.64 %
Free-Float capitalization (CNY)
5 543 898 928
Free-Float capitalization (USD)
766 654 695
Average Daily Capital Traded
0.98%
Highs and lows
1 week
15.50
17.06
1 month
15.0517.06
Current year
12.8820.35
1 year
12.8821.77
3 years
12.8828.67
5 years
12.8834.77
10 years
12.8879.58
Indicators
Moving average 5 days
16.36
Moving average 20 days
16.05
Moving average 50 days
16.37
Moving average 100 days
17.53
Price spread / (MMA5)
-3.59%
Price spread / (MMA20)
-5.42%
Price spread / (MMA50)
-3.54%
Price spread / (MMA100)
+3.30%
STIM
RSI 9 days
69.22
RSI 14 days
60.96
Sector Comparison - Diagnostic & Testing Substances
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.16% | +10.05% | -16.28% | -6.19% | 1.06B | ||
| +0.79% | +1.59% | +1.69% | +7.14% | 12.8B | ||
| +3.04% | +11.75% | -7.57% | +36.69% | 7.61B | ||
| +1.41% | +1.37% | +3.22% | -1.51% | 5.41B | ||
| +2.11% | +6.01% | +0.93% | +0.54% | 4.51B | ||
| +2.59% | +6.64% | +8.48% | -19.32% | 4.49B | ||
| -2.67% | +1.45% | +9.21% | -8.56% | 2.73B | ||
| +2.69% | +2.44% | -13.87% | -27.21% | 2.02B | ||
| -0.15% | +20.63% | -11.63% | -11.43% | 1.73B | ||
| +8.91% | +7.08% | +3.45% | -8.76% | 1.64B | ||
| +3.45% | +9.28% | -5.65% | +48.15% | 1.53B | ||
| +5.72% | +9.62% | +3.12% | +7.63% | 1.51B | ||
| +4.17% | +8.32% | -3.19% | -20.98% | 1.44B | ||
| +1.53% | +3.70% | -0.45% | -22.25% | 1.17B | ||
| +0.56% | +13.29% | -11.77% | -23.76% | 1.17B | ||
| +1.57% | +10.89% | -14.20% | -21.30% | 1.08B | ||
| Average | +2.41% | +4.59% | -3.41% | -4.45% | ||
| Weighted average by Cap. | +1.95% | +3.69% | -0.94% | +2.65% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -16.28% | ||
| 2023 | +19.17% | ||
| 2022 | -32.61% | ||
| 2021 | +28.71% | ||
| 2020 | +15.83% | ||
| 2019 | +4.25% | ||
| 2018 | -42.82% | ||
| 2017 | +5.97% | ||
| 2016 | -58.78% | ||
| 2015 | +60.48% | ||
| 2014 | +69.07% | ||
| 2013 | +33.56% | ||
| 2012 | -21.28% | ||
| 2011 | +142.96% | ||
| 2010 | +24.57% | ||
| 2009 | +93.08% | ||
| 2008 | -50.82% | ||
| 2007 | +208.18% | ||
| 2006 | +49.66% | ||
| 2005 | -25.13% | ||
| 2004 | -70.25% | ||
| 2003 | -19.77% | ||
| 2002 | +11.61% | ||
| 2001 | +5.28% | ||
| 2000 | +98.66% | ||
| 1999 | +13.59% | ||
| 1998 | +16.55% | ||
| 1997 | +25.64% | ||
| 1996 | -4.94% |
- Stock Market
- Equities
- 600645 Stock
- Quotes Vcanbio Cell & Gene Engineering Corp., Ltd
